Mixed chemicals in beauty products may harm women's hormones

September 13, 2018

As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones. These hormonal changes have been linked to several adverse health outcomes such as breast cancer and cardiovascular disease. Therefore, understanding chemicals that influence hormone levels is important for public health--and particularly for women's health--since their exposure to these chemicals is often higher due to their presence in beauty and personal care products.

A new study published in Environment International by George Mason University Assistant Professor of Global and Community Health Dr. Anna Pollack and colleagues discovered links between chemicals that are widely used in cosmetic and personal care products and changes in reproductive hormones.

A total of 509 urine samples were collected from 143 women aged 18 to 44 years, free of known chronic health conditions and birth control to be measured for environmental chemicals that are found in personal care products, such as parabens, which are antimicrobial preservatives, and benzophenones, which are ultraviolet filters.

"This study is the first to examine mixtures of chemicals that are widely used in personal care products in relation to hormones in healthy, reproductive-age women, using multiple measures of exposure across the menstrual cycle, which improved upon research that relied on one or two measures of chemicals," Pollack noted.

This multi-chemical approach more closely reflects real world environmental exposures and shows that even low-level exposure to mixtures of chemicals may affect reproductive hormone levels. Another noteworthy finding of the study is that certain chemical and UV filters were associated with decreased reproductive hormones in multi-chemical exposures while others were associated with increases in other reproductive hormones, underscoring the complexities of these chemicals.

"What we should take away from this study is that we may need to be careful about the chemicals in the beauty and personal care products we use," explains Pollack. "We have early indicators that chemicals such as parabens may increase estrogen levels. If this finding is confirmed by additional research, it could have implications for estrogen dependent diseases such as breast cancer."
-end-
About George Mason University

George Mason University is Virginia's largest and most diverse public research university. Located near Washington, D.C., Mason enrolls 37,000 students from 130 countries and all 50 states. Mason has grown rapidly over the past half-century and is recognized for its innovation and entrepreneurship, remarkable diversity and commitment to accessibility.

George Mason University

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.